questionText: To ask the Secretary of State for Health and Social Care, with reference to Association of the British Pharmaceutical Industry’s publication entitled At the crossroads: how a new UK medicines deal can deliver for patients, the NHS and the economy, published on 1 March 2023, what assessment he has made of the potential implications for his policies of that publication's proposals to lower the tax rebate for the voluntary scheme for branded medicines pricing and access.
answerText: The Department carefully considers all evidence in the public domain on matters relating to the pricing of medicines in the United Kingdom, including the March report by the Association of the British Pharmaceutical Industry (ABPI). The Voluntary Scheme f...
heading: Voluntary Scheme for Branded Medicines Pricing and Access